[Summary] An innovative pharmaceutical enterprise engaged in the R&D and industr
Hairong Pharma, a pharmaceutical enterprise adhering to innovation-driven development and a differentiated competitive strategy in R&D of products, possesses leading-class R&D technology for active vitamin D derivative drugs and multiple R&D pipelines for innovative drugs and improved new drugs, and is committed to providing patients with better therapeutic drugs and making life more valuable.
Guided by clinical and patient needs, Hairong Pharma focuses on independent R&D of innovative drugs, improved new drugs and high-end generic drugs in five therapeutic areas: analgesia, dermatology, orthopedics, nephrology and anti-infection, carries out joint R&D of cell therapy drugs, and builds R&D technology platforms and a rich R&D pipeline with Hairong characteristics.
At present, Hairong Pharma has more than 30 R&D pipelines at different stages, of which innovative drugs and improved new drugs account for more than half. In the nine years since its establishment, the company has obtained production approvals and clinical approvals for more than 10 projects, among which Haifurun® Tacalcitol Ointment is a first-line recommended drug for the treatment of psoriasis, Regadenoson Injection is an urgently needed drug for clinical diagnosis of myocardial ischemia, and the innovative drug project HR1405-01 in the field of analgesia can effectively reduce the clinical use of opioid addictive drugs. In the next 2-3 years, Hairong Pharma will also obtain 5-6 production approvals and 2-3 clinical approvals. Up to now, the company has applied for 107 patents, of which 50 have been authorized, and 8 PCT patents.
Centering on the expectations for a higher and broader level of life, health and social needs, and fulfilling social responsibilities with its own professionalism and technology, Hairong Pharma is gathering more diversified resources, and through its holding companies Nanjing Ruizhi Biopharmaceutical Co., Ltd., carries out R&D and technical services for anti-infective drugs and peptide drugs; Nanjing Canchen Microbiology Technology Co., Ltd. expands microbial testing, challenge tests and the control and treatment of related microorganisms and pathogenic bacteria; and Haibo (Shanghai) Pharmaceutical Technology Co., Ltd. is committed to the international promotion and trade of high-quality APIs and excipients in the fields of human and animal drug manufacturing.
Recruitment contact: *** Contact information: *********** (same number on WeChat)
Resume submission email: hr@*
Company WeChat official accounts: Hairong Pharma / Hairong Recruitment. Please follow us for more information.
What does Nanjing Hairong Pharmaceutical Technology Co., Ltd. require? Who is Hairong Pharma hiring? Hairong Pharma recruitment: Sales占比最多占33.3%,其次是Biology/Pharmaceutical/Chemical/Environmental Protection占17.6%. What education can get in at Hairong Pharma? 大专占比最多占52.9%,其次是本科占37.3%. High education required at Hairong Pharma? 硕士占5.9%. Work experience required at Hairong Pharma? 3-5年占比最多占49%,其次是不限占25.5%. Where are the job locations at Hairong Pharma? 南京占比最多占70.6%,其次是重庆占7.8%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows